ATE554758T1 - Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs - Google Patents
Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebsInfo
- Publication number
- ATE554758T1 ATE554758T1 AT05724487T AT05724487T ATE554758T1 AT E554758 T1 ATE554758 T1 AT E554758T1 AT 05724487 T AT05724487 T AT 05724487T AT 05724487 T AT05724487 T AT 05724487T AT E554758 T1 ATE554758 T1 AT E554758T1
- Authority
- AT
- Austria
- Prior art keywords
- triptolide
- lactone ring
- cancer agent
- immune modulators
- ring derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54976904P | 2004-03-02 | 2004-03-02 | |
PCT/US2005/006952 WO2005084365A2 (en) | 2004-03-02 | 2005-03-02 | Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE554758T1 true ATE554758T1 (de) | 2012-05-15 |
Family
ID=34919536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05724487T ATE554758T1 (de) | 2004-03-02 | 2005-03-02 | Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs |
Country Status (10)
Country | Link |
---|---|
US (2) | US7863464B2 (de) |
EP (1) | EP1732536B1 (de) |
JP (1) | JP5057966B2 (de) |
CN (1) | CN100558354C (de) |
AT (1) | ATE554758T1 (de) |
AU (1) | AU2005218610B2 (de) |
CA (1) | CA2557260C (de) |
DK (1) | DK1732536T3 (de) |
ES (1) | ES2385716T3 (de) |
WO (1) | WO2005084365A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4680589B2 (ja) * | 2002-05-31 | 2011-05-11 | ファーマジェネシス, インコーポレイテッド | アポトーシスおよび免疫抑制の調節のためのトリプトリド誘導体 |
WO2005062913A2 (en) * | 2003-12-24 | 2005-07-14 | Pharmagenesis, Inc. | Triplide 5,6-derivatives as immunomodulators and anticancer agents |
EP1722806A4 (de) * | 2004-02-09 | 2009-09-16 | Pharmagenesis Inc | Verfahren zur isolierung von triptolid-verbindungen aus tripterygium wilfordii |
EP1732536B1 (de) | 2004-03-02 | 2012-04-25 | Pharmagenesis, Inc. | Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs |
US8617906B2 (en) * | 2004-10-13 | 2013-12-31 | Pharmagenesis, Inc. | Identification and screening of triptolide target molecules |
CA2750844A1 (en) * | 2009-02-05 | 2010-08-12 | Pharmagenesis, Inc. | Triptolide c-ring derivatives as anticancer agents and immune modulators |
KR101821823B1 (ko) | 2009-05-07 | 2018-01-24 | 리전츠 오브 더 유니버스티 오브 미네소타 | 트립톨라이드 전구약물 |
US9150600B2 (en) | 2009-05-07 | 2015-10-06 | Regents Of The University Of Minnesota | Triptolide prodrugs |
EP2968140A4 (de) * | 2013-03-15 | 2016-11-16 | Pharmagenesis Inc | Intravenöse emulsionen von triptolid als immunmodulatoren und antikrebsmittel i |
WO2015127011A1 (en) | 2014-02-21 | 2015-08-27 | Institute Of Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | C-myc as a biomarker for tumor sensitivity to treatment with rna polymerase ii inhibition |
WO2016181312A1 (en) * | 2015-05-11 | 2016-11-17 | Versitech Limited | Polycyclic epoxides and compositions thereof with anti-cancer activities |
CN107663225A (zh) * | 2016-07-29 | 2018-02-06 | 欣凯医药化工中间体(上海)有限公司 | 一种氟代雷公藤内酯醇内酯环衍生物 |
CN106749496A (zh) * | 2016-12-05 | 2017-05-31 | 张奇军 | 新型雷公藤甲素衍生物、及其制备和用途 |
CN108530511B (zh) * | 2017-03-02 | 2021-06-22 | 欣凯医药化工中间体(上海)有限公司 | 一种c19-酰基化雷公藤甲素衍生物 |
CN108530510A (zh) * | 2017-03-02 | 2018-09-14 | 欣凯医药化工中间体(上海)有限公司 | 一种c19-酰基化雷公藤甲素的制备方法 |
WO2018222351A1 (en) * | 2017-05-27 | 2018-12-06 | Pharmagenesis, Inc. | Triptolide lactone derivatives as immunomodulators and anticancer agents |
CN109942665B (zh) * | 2018-04-02 | 2021-04-06 | 欣凯医药化工中间体(上海)有限公司 | 雷公藤内酯醇衍生物及其制备方法和应用 |
CN110551171B (zh) * | 2018-05-31 | 2021-07-27 | 欣凯医药化工中间体(上海)有限公司 | 一种雷公藤内酯醇衍生物的制备方法 |
CN110551170B (zh) * | 2018-05-31 | 2022-04-22 | 欣凯医药化工中间体(上海)有限公司 | 一种c-19位单酰基化雷公藤内酯醇衍生物的合成方法 |
CN110551172B (zh) * | 2018-05-31 | 2021-08-27 | 欣凯医药化工中间体(上海)有限公司 | 一种c-19位双键化雷公藤内酯醇衍生物的合成方法 |
CN111909119B (zh) * | 2020-08-25 | 2023-06-16 | 上海诗丹德标准技术服务有限公司 | 雷公藤来源化合物及其应用和制备方法、药物组合物、杀虫剂 |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4005108A (en) | 1973-04-03 | 1977-01-25 | Research Corporation | Novel anti-leukemic diterpenoid triepoxides |
CA1310009C (en) | 1984-03-28 | 1992-11-10 | John Mark Braughler | Ester prodrugs of steroids |
CN1027371C (zh) | 1989-09-08 | 1995-01-11 | 中国医学科学院皮肤病研究所 | 二萜内酯化合物的合成方法 |
US5430054A (en) * | 1989-12-22 | 1995-07-04 | Jiangsu Family Planning Institute | Preparation methods of diterpene lactone compounds and application of the same to antifertility |
CN1052859A (zh) | 1989-12-22 | 1991-07-10 | 中国医学科学院皮肤病研究所 | 17-羟基雷藤内酯醇及类似物的结构与制备方法 |
ES2069281T3 (es) * | 1990-03-06 | 1995-05-01 | Otsuka Pharma Co Ltd | Derivado de fenantreno. |
US5580562A (en) * | 1990-03-14 | 1996-12-03 | Board Of Regents The University Of Texas System | Preparations and uses thereof for immunosuppression |
WO1991013627A1 (en) | 1990-03-14 | 1991-09-19 | The Board Of Regents, The University Of Texas System | Tripterygium wilfordii hook f extracts and components thereof for immunosuppression |
US5843452A (en) * | 1992-11-09 | 1998-12-01 | Pharmagenesis, Inc. | Immunotherapy composition and method |
US5468772A (en) * | 1993-03-10 | 1995-11-21 | Pharmagenesis, Inc. | Tripterinin compound and method |
US5759550A (en) * | 1993-05-06 | 1998-06-02 | Pharmagenesis, Inc. | Method for suppressing xenograft rejection |
AU6826194A (en) | 1993-05-06 | 1994-12-12 | Pharmagenesis, Inc. | 16-hydroxytriptolide composition and method for immunotherapy |
US5919816A (en) * | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
US5648376A (en) * | 1995-01-19 | 1997-07-15 | Pharmagenesis, Inc. | Immunosuppressant diterpene compound |
US5663335A (en) | 1996-03-01 | 1997-09-02 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
US5994064A (en) * | 1996-04-24 | 1999-11-30 | Identigene, Inc. | Simple and complex tandem repeats with DNA typing method |
WO1998023281A1 (en) * | 1996-11-26 | 1998-06-04 | Pharmagenesis, Inc. | ANTIFUNGAL COMPOUNDS FROM $i(PSEUDOMONAS VIRIDIFLAVA) |
US5962516A (en) | 1997-02-28 | 1999-10-05 | Pharmagenesis, Inc. | Immunosuppressive compounds and methods |
ATE261434T1 (de) | 1997-05-23 | 2004-03-15 | Aventis Pharma Inc | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten |
DE69807466T2 (de) | 1997-05-23 | 2003-04-24 | Aventis Pharma Inc | Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten |
US6004999A (en) | 1997-05-23 | 1999-12-21 | Hoechst Marion Roussel, Inc. | Triptolide derivatives useful in the treatment of autoimmune diseases |
US5972998A (en) | 1997-05-23 | 1999-10-26 | Hoechst Marion Roussel, Inc. | Triptolide derivatives useful in the treatment of autoimmune diseases |
US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
ATE334969T1 (de) | 1998-09-02 | 2006-08-15 | Pharmagenesis Inc | Triptolid-prodrugs mit hoher wasserlöslichkeit |
US6548537B1 (en) * | 1998-09-02 | 2003-04-15 | Pharmagenesis, Inc. | Triptolide prodrugs having high aqueous solubility |
US6329148B1 (en) * | 1999-02-16 | 2001-12-11 | The Board Of Trustees Of The Leland Stanford University | Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells |
WO2000063212A1 (en) | 1999-04-16 | 2000-10-26 | Chengdu Diao Pharmaceutical Group Company Limited | Derivatives of triptolide, and preparation and uses thereof |
US6294546B1 (en) * | 1999-08-30 | 2001-09-25 | The Broad Of Trustees Of The Leland Stanford Junior University | Uses of diterpenoid triepoxides as an anti-proliferative agent |
CN1317248A (zh) | 2000-04-13 | 2001-10-17 | 福建省医学科学研究所 | 紫雷藤杀虫剂及其制备方法 |
US20020077350A1 (en) * | 2000-08-01 | 2002-06-20 | Ashni Naturaceuticals, Inc. | Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2 |
WO2002017931A1 (fr) | 2000-09-01 | 2002-03-07 | Xiaomin Wang | Utilisation d'un ou de plusieurs extraits de tripterygium wilfordii hook.f pour la preparation de medicaments destines a prevenir et a traiter des troubles du systeme nerveux |
DE60121986T2 (de) * | 2000-10-02 | 2007-07-26 | Emory University | Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen |
US6620843B2 (en) * | 2001-01-19 | 2003-09-16 | Pharmagenesis | Anticancer treatment using triptolide prodrugs |
EP1390358A4 (de) | 2001-03-15 | 2004-06-16 | Pharmagenesis Inc | Aminosäurederivate von triptolidverbindungen als immunmodulatoren und antikrebsmittel |
JP4680589B2 (ja) * | 2002-05-31 | 2011-05-11 | ファーマジェネシス, インコーポレイテッド | アポトーシスおよび免疫抑制の調節のためのトリプトリド誘導体 |
US20040018260A1 (en) * | 2002-06-19 | 2004-01-29 | Novemed Group Limited | Novel botanical extract of Tripterygium Wilfordii Hook F. |
CA2508217A1 (en) * | 2002-12-17 | 2004-07-15 | Pharmagenesis, Inc. | Triptolide derivatives as immunomodulators and anticancer agents |
US6943259B2 (en) * | 2003-02-25 | 2005-09-13 | Pharmagenesis, Inc. | Halogenated triptolide derivatives as immunomodulators and anticancer agents |
WO2005000291A1 (en) * | 2003-06-27 | 2005-01-06 | Pharmagenesis, Inc. | Method for treatment of idiopathic pulmonary fibrosis using triptolide derivatives |
WO2005062913A2 (en) | 2003-12-24 | 2005-07-14 | Pharmagenesis, Inc. | Triplide 5,6-derivatives as immunomodulators and anticancer agents |
EP1722806A4 (de) * | 2004-02-09 | 2009-09-16 | Pharmagenesis Inc | Verfahren zur isolierung von triptolid-verbindungen aus tripterygium wilfordii |
EP1732536B1 (de) | 2004-03-02 | 2012-04-25 | Pharmagenesis, Inc. | Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs |
US20070244080A1 (en) * | 2004-06-25 | 2007-10-18 | Pharmagenesis, Inc. | Method for Treatment of Inflammatory Disorders Using Triptolide Compounds |
-
2005
- 2005-03-02 EP EP05724487A patent/EP1732536B1/de not_active Not-in-force
- 2005-03-02 CN CNB2005800068751A patent/CN100558354C/zh active Active
- 2005-03-02 WO PCT/US2005/006952 patent/WO2005084365A2/en active Application Filing
- 2005-03-02 US US10/591,358 patent/US7863464B2/en not_active Expired - Fee Related
- 2005-03-02 CA CA2557260A patent/CA2557260C/en not_active Expired - Fee Related
- 2005-03-02 AU AU2005218610A patent/AU2005218610B2/en not_active Ceased
- 2005-03-02 ES ES05724487T patent/ES2385716T3/es active Active
- 2005-03-02 AT AT05724487T patent/ATE554758T1/de active
- 2005-03-02 JP JP2007501990A patent/JP5057966B2/ja not_active Expired - Fee Related
- 2005-03-02 DK DK05724487.3T patent/DK1732536T3/da active
-
2010
- 2010-09-02 US US12/874,434 patent/US8426616B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1732536A2 (de) | 2006-12-20 |
CA2557260C (en) | 2013-02-12 |
DK1732536T3 (da) | 2012-06-25 |
WO2005084365A3 (en) | 2005-11-10 |
JP2007526331A (ja) | 2007-09-13 |
ES2385716T3 (es) | 2012-07-30 |
AU2005218610B2 (en) | 2011-08-18 |
CN100558354C (zh) | 2009-11-11 |
JP5057966B2 (ja) | 2012-10-24 |
US7863464B2 (en) | 2011-01-04 |
US20080287530A1 (en) | 2008-11-20 |
CA2557260A1 (en) | 2005-09-15 |
EP1732536A4 (de) | 2009-06-10 |
AU2005218610A1 (en) | 2005-09-15 |
EP1732536B1 (de) | 2012-04-25 |
US20100331554A1 (en) | 2010-12-30 |
WO2005084365A2 (en) | 2005-09-15 |
US8426616B2 (en) | 2013-04-23 |
CN1925852A (zh) | 2007-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE554758T1 (de) | Triptolid-lacton-ring-derivate als immunmodulatoren und mittel gegen krebs | |
NO20170633A1 (no) | Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff . | |
CL2012001080A1 (es) | Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida. | |
CL2009000380A1 (es) | Compuestos derivados de heterociclos, moduladores de beta-amiloide; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de la enfermedad de alzheimer, angioplastia cerebral amiloide, demencia multiinfarto, sindrome de down, entre otras. | |
CL2011000043A1 (es) | Compuestos derivados de benzoazepina sustituidos; compuestosintermediarios; metodo de sintesis; composicion farmaceutica; y uso en el tratamiento o prevencion de un trastorno del sistema nervioso central. | |
ATE389398T1 (de) | Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen | |
UY28736A1 (es) | Derivados de quinazolina | |
CL2007002642A1 (es) | Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer. | |
DE602007006519D1 (de) | Oxindolderivate als antikrebsmittel | |
CL2008003188A1 (es) | Compuestos derivados de piridina y pirazina; composicion farmaceutica que los comprende;y su uso en el tratamiento o prevencion de tumores sensibles a la inhibicion de enzimas del receptor ax1 y/o c-met. | |
CL2011000116A1 (es) | Compuestos derivados de imidazo[1,2-a]piridina; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y uso en el tratamiento del cancer. | |
CL2008001373A1 (es) | Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer. | |
CL2008002049A1 (es) | Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
NO20090251L (no) | Camptotecinderivater med antitumoraktivitet | |
TR200200821T2 (tr) | 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı. | |
ATE388149T1 (de) | Neue azaindol-thiazolinone als krebsmittel | |
CL2011000979A1 (es) | Compuestos derivados ftalazina 1,4-disustituida; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
WO2019118411A3 (en) | Anti-cd22 antibody-maytansine conjugates, combinations, and methods of use thereof | |
TR201901390T4 (tr) | Demodikoza karşı madde. | |
WO2007076160A3 (en) | C-10 carbamates of taxanes | |
ATE419244T1 (de) | Neue cycloalkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel | |
DE602006002887D1 (de) | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel | |
EP1503748A4 (de) | Arzneimittel zur linderung durch taxan induzierte neurotoxizität | |
ATE539082T1 (de) | Oxazinylisoflavonoidverbindungen, medikamente und anwendungen | |
HK1120417A1 (en) | Stable nanoparticle formulations |